Table 3.
n | TOX+ (%) | TOX+ >2* (%) | |
---|---|---|---|
MF | 53 | 39 (73.6) | 33 (62.3) |
CD30+LPD | 20 | 10 (50) | 1 (5) |
LyP | 9 | 2 (22.2) | 0 (0) |
C-ALCL | 8 | 6 (75) | 1 (12.5) |
S-ALCL | 3 | 2 (66.7) | 0 (0) |
LPP | 10 | 7 (70.0) | 5 (50.0) |
n | TOX+ (%) | TOX+ >2* (%) | |
---|---|---|---|
MF | 53 | 39 (73.6) | 33 (62.3) |
CD30+LPD | 20 | 10 (50) | 1 (5) |
LyP | 9 | 2 (22.2) | 0 (0) |
C-ALCL | 8 | 6 (75) | 1 (12.5) |
S-ALCL | 3 | 2 (66.7) | 0 (0) |
LPP | 10 | 7 (70.0) | 5 (50.0) |